LDL-apheresis in acute anterior ischemic optic neuropathy

International Journal of Artificial Organs

Volumn 27, Issue 4, 2004, Pages 337-341

  Ramunni, Alfonso ^a   Giancipoli, G ^a   Saracino, A ^a   Guerriero, S ^a   Saliani, M T ^a   Gentile, M C ^a   Sborgia, C ^a   Coratelli, P ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Anterior ischemic optic neuropathy; Hypercholesterolemia; LDL apheresis; Visual function

Indexed keywords

PATIENT TREATMENT;

ANTERIOR ISCHEMIC OPTIC NEUROPATHY; BENEFICIAL EFFECTS; CONDITION; HYPERCHOLESTEROLEMIA; LDL CHOLESTEROL; LDL-APHERESIS; OPTIC NEUROPATHIES; RISK FACTORS; VISUAL FIELDS; VISUAL FUNCTIONS;

MICROCIRCULATION;

FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTICOAGULATION; APHERESIS; ARTICLE; BLOOD RHEOLOGY; CASE REPORT; CHOLESTEROL BLOOD LEVEL; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC OPTIC NEUROPATHY; MICROCIRCULATION; OCULAR BLOOD VESSEL; RISK FACTOR; SCOTOMA; VISUAL FIELD DEFECT;

EID: 2942687150     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402700410     Document Type: Article

References (26)

1. Peyman GA, Sanders D, Goldberg M. Oftalmologia: Principi e Pratica. Verducci ed. 1983; 31: 2099-103.
2. Yannuzzi L, Flower R, Slakter J. Angiografia con verde di indocianina. Medical Books 1999; 2: 21-3.
3. Hollenhorst RW. Effect of posture on retinal ischemia from temporal arteritis. Arch Ophthalmol 1967; 78: 569-72.
4. Norton AL, Walsh FB. Disulfiram-induced optic neuritis. Trans Am Acad Ophthalmol Otolaryngol 1972; 76: 1263-69.
5. Menezo J, Diaz M, Marin F. Atlante di Fluoroangiografia Clinica. Fogliazza ed. 1991; 7: 252-60.
6. Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study of Missouri and Los Angeles County, California. J Neuro-ophthalmol 1994; 14: 38-44.
7. Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997; 123: 103-7.
8. Aengevaeren WR, Kroon AA, Stalenhoef AF, Uijen GJ, van der Werf T. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS). J Am Coll Cardiol 1996; 28: 1696-704.
9. Mii S, Mori A, Sakata H, Nakayama M, Tsuruta H. LDL apheresis for arteriosclerosis obliterans with occluded bypass graft: Change in prostacyclin and effect on ischemic symptoms. Angiology 1998; 49: 175-80.
10. Mellwig KP, Baller D, Gleichmann U, Moll D, Betker S, Weise R, Notohamiprodjo G. Improvement of coronary vasodilation capacity through single LDL apheresis. Atherosclerosis 1998; 139: 173-8.
11. Jaeger BR, Marx P, Pfefferkorn T, Hamman FG, Seidel D. Heparin-induced extracorporeal LDL/fibrinogen precipitation - HELP- in coronary and cerebral ischemia. Acta Neurochir 1999; 73 (suppl): S81-4.
12. Bosch T, Wendler T, Jaeger BR, Samtleben W. Improvement of hemorheology by DALI apheresis: Acute effects on plasma viscosity and erythrocyte aggregation in hypercholesterolemic patients. Ther Apher 2001; 5 : 372-76.
13. Casten O, Geiss HC, Laubach E, Schwandt P. Effects of direct adsorption of lipoprotein apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hyper-cholesterolemic patients with coronary artery disease. Ther Apher 2002; 6: 130-35.
14. Jaeger BR. Evidence for maximal treatment of atherosclerosis: Drastic reduction of cholesterol and fibrinogen restores vascular homeostasis. Ther Apher 2001; 5: 207-11.
15. Cattin L, Petrucco A, Cazzolato G, et al. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocytes adhesion to endothelial cells. ASAIO J 1997; 43: 209-13.
16. Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999; 48: 1856-62.
17. Makin AJ, Chung NA, Silverman SH, Lip GY. Thrombogenesis and endothelial/dysfunction in peripheral artery disease. Relationship to ethnicity and disease severity. Thromb Res 2003; 111: 221-6.
18. Knisel W, Nicuolo A, Pfohl M, Muller H, Risler T, Eggstein M, Se E. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems. J Intern Med 1993; 234: 479-87.
19. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. A marker of atherosclerotic risk. ATVB 2003; 23: 168-75.
20. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993; 88: 2541-47.
21. Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 1997; 96: 3287-93.
22. Stroes ES, Koomans HA, De Bruin TW, Rabelink TJ. Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication. Lancet 1995; 346: 467-71.
23. Tamai O, Matsuoka H, Itable H Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation 1997; 95: 76-82.
24. Suckfull M. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002; 360: 1811-17.
25. Mabuchi H, Koizumi J, Shimizu M, Kajnami K, Miyamoto S, Veda K, Takegoshi T. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Am J Cardiol 1998, 82: 1489-95.
26. Ramunni A, Morrone LF, Baldassarre G, Montagna E, Saracino A, Coratelli P. Effectiveness of long-term heparin-induced extracorporeal LDL precipitation (HELP) in improving coronary calcifications. Int J Artif Organs 2003; 26: 252-5.